Efficacy of early pegylated interferon α-2b monotherapy for acute hepatitis C in HIV-infected patients

Clinical Infectious Diseases

Volumn 48, Issue 11, 2009, Pages 1636-1637

  De Rosa, Francesco G ^a,b   Mollaretti, Oscar ^a   Audagnotto, Sabrina ^a   De Blasi, Tiziano ^a   Cariti, Giuseppe ^a   Marucco, Diego M Aguilar ^a   Bonora, Stefano ^a   Perri, Giovanni Di ^a  

^a AMEDEO DI SAVOIA HOSPITAL   (Italy)

^b Clinica Malattie Infettive Ospedale Amedeo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B; RIBAVIRIN; ALPHA2B INTERFERON; ANTIVIRUS AGENT; PEGINTERFERON ALFA-2B;

ACUTE HEPATITIS; ADULT; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; MALE; MONOTHERAPY; PRIORITY JOURNAL; TREATMENT DURATION; CASE REPORT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 66949161148     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598995     Document Type: Letter

References (6)

1. Jaeckel E, Cornberg M, Wedemeyer H, et al. Treatment of acute hepatitis C with interferon a-2b. N Engl J Med 2001;345:1452-7.
2. Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C. Lancet 2008;372:321-32.
3. Dominguez S, Bhagani S, Vogel M, et al. High rate ofsustained virological response to an early course of anti-HCV treatment for acute HCV hepatitis in HIV+ patients [abstract 1072]. In: Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections (Boston). 2008.
4. Vogel M, Bieniek B, Jessen H, et al. Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis ofeleven cases. J Viral Hepat 2005; 12:207-11.
5. Gilleece YC, Browne RE, Asboe D, et al. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ri-bavirin. J Acquir Immune Defic Syndr 2005; 40:41-6.
6. Soriano V, Puoti M, Sulkowski M, et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HIV-HCV International Panel. AIDS 2007;21:1073-89.